Firm gets money for Photopneumatic Technology (PPx) apps

Aesthera Corp. Secures $11 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
Wednesday February 22, 9:00 am ET
Former President of Guidant Vascular Intervention Joins Aesthera Board

PLEASANTON, Calif., Feb. 22 /PRNewswire/ – Aesthera Corp., a leader in developing innovative photopneumatic-based aesthetic treatment systems, today announced it has secured $11 million in its third round of venture funding. The investment was led by the preeminent venture capital firm Kleiner Perkins Caufield & Byers (KPCB), with participation from existing investors MedVenture Associates and Adams Street Partners.

The oversubscribed venture capital round further validates Aesthera’s growth potential in offering the only clinically proven no-pain treatment for permanent hair reduction and skin rejuvenation. The additional investment will be used to continue driving the company’s research and development of innovative applications for its proprietary Photopneumatic Technology (PPx), and to further expand Aesthera’s global sales channels and marketing efforts.

I was wondering if this product is available to the public and if not do they say when it will be available. Just wondering. And if anyone has used it, whats there thoughts on it

The U.S. Food and Drug Administration cleared the Aesthera Photopneumatic (PPx) System, for the treatment of vascular and pigmented lesions and permanent hair reduction in summer 2005.

You can contact Aesthera directly about finding a physician in your area, but there isn’t much market presence yet.